Skip to main content

Table 1 Demographics of the population undergoing ABPM testing one or more times during the analysis period (n = 245).

From: Favorable patient acceptance of ambulatory blood pressure monitoring in a primary care setting in the United States: a cross-sectional survey

Age (in years)  
   Mean ± SD 52.6 ± 16.3
   (Range) (17–86)
Gender  
   Female 119 (49%)
   Male 126 (51%)
Indication for ABPMa  
   Evaluation of blood pressure control 71 (29%)
   Borderline hypertensionb 62 (25%)
   Suspected white-coat hypertension 60 (24%)
   Treatment resistance 19 (8%)
   Other 33 (13%)
Outcome Resulting from ABPMa  
   Medication initiated 51 (21%)
   Diagnosed white-coat hypertension 49 (20%)
   No change in therapy (blood pressure controlled) 37 (15%)
   Medication changed 31 (13%)
   Dose/regimen adjusted 21 (9%)
   Recommend lifestyle modifications 14 (6%)
   Other/unknown 42 (18%)
  1. a categories are mutually exclusive b defined as those patients with office blood pressures that are elevated into the Stage 1 range at some visits, but also in the pre-hypertension range (per JNC-VII classification – ref. [10]) at other visits. These patients are untreated and have not been officially diagnosed with hypertension.